Clorox
CLX · NYSESpecialty Cleaning, Polishing and Sanitation Preparations · Fiscal year ends Jun 30
Clorox reported revenue of $7.1B in the fiscal year ended Jun 2025, up 0.2% from the year before. Net income was $810M. Operating cash flow of $981M less capital expenditure of $220M left free cash flow of $761M. Net debt was $2.3B.
Last 5 fiscal years
Revenue and net income
Income statement
| Fiscal year | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | $7.3B | $7.1B | $7.4B | $7.1B | $7.1B |
| Cost of revenue | $4.1B | $4.6B | $4.5B | $4B | $3.9B |
| Gross profit | $3.2B | $2.5B | $2.9B | $3B | $3.2B |
| Research & development | $149M | $132M | $138M | $126M | $121M |
| Selling, general & admin | $1B | $954M | $1.2B | $1.2B | $1.1B |
| Interest expense | $99M | $106M | $90M | $90M | $88M |
| Pre-tax income | $900M | $607M | $238M | $398M | $1.1B |
| Income tax | $181M | $136M | $77M | $106M | $254M |
| Net income | $710M | $462M | $149M | $280M | $810M |
| Diluted EPS | 5.58 | 3.73 | 1.20 | 2.25 | 6.52 |
| Diluted shares | 127M | 124M | 124M | 125M | 124M |
Balance sheet
| Fiscal year | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $319M | $183M | $367M | $202M | $167M |
| Receivables | $604M | $681M | $688M | $695M | $821M |
| Inventory | $752M | $755M | $696M | $637M | $523M |
| Current assets | $1.8B | $1.7B | $1.8B | $1.6B | $1.6B |
| Net PP&E | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B |
| Goodwill | $1.6B | $1.6B | $1.3B | $1.2B | $1.2B |
| Total assets | $6.3B | $6.2B | $5.9B | $5.8B | $5.6B |
| Payables | $930M | $960M | $1B | $950M | $838M |
| Current liabilities | $2.1B | $1.8B | $1.9B | $1.6B | $1.9B |
| Short-term debt | $300M | $0 | $0 | $0 | $0 |
| Long-term debt | $2.5B | $2.5B | $2.5B | $2.5B | $2.5B |
| Total liabilities | $5.7B | $5.4B | $5.6B | $5.3B | $5.1B |
| Shareholders' equity | $411M | $556M | $220M | $328M | $321M |
Cash flow
| Fiscal year | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $1.3B | $786M | $1.2B | $695M | $981M |
| Capital expenditure | $331M | $251M | $228M | $212M | $220M |
| Free cash flow | $945M | $535M | $930M | $483M | $761M |
| Depreciation & amortisation | $211M | $224M | $236M | $235M | $219M |
| Stock-based compensation | $50M | $52M | $73M | $74M | $81M |
| Acquisitions | $85M | $0 | $0 | – | – |
| Share buybacks | $905M | $25M | $0 | $0 | $332M |
| Dividends paid | $558M | $571M | $583M | $595M | $602M |
| Dividend per share | 4.49 | 3.48 | 4.72 | 4.80 | 4.88 |
Key ratios
| Fiscal year | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | −3.2% | 4.0% | −4.0% | 0.2% |
| EPS growth (YoY) | – | −33.2% | −67.8% | 87.5% | 189.8% |
| Gross margin | 43.6% | 35.8% | 39.4% | 43.0% | 45.2% |
| Net margin | 9.7% | 6.5% | 2.0% | 3.9% | 11.4% |
| Return on equityBlank when equity is negative | 172.7% | 83.1% | 67.7% | 85.4% | 252.3% |
| Free cash flow margin | 12.9% | 7.5% | 12.6% | 6.8% | 10.7% |
| Cash conversion (CFO ÷ net income) | 1.80x | 1.70x | 7.77x | 2.48x | 1.21x |
| Receivable days | 30 | 35 | 34 | 36 | 42 |
| Inventory days | 66 | 60 | 57 | 57 | 49 |
| Payable days | 82 | 77 | 83 | 86 | 79 |
| Debt ÷ equity | 6.77x | 4.45x | 11.3x | 7.56x | 7.74x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | $2.5B | $2.3B | $2.1B | $2.3B | $2.3B |
| Current ratio | 0.89x | 0.97x | 0.95x | 1.03x | 0.84x |
Recent filings
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.